|
J Biol Chem, Vol. 273, Issue 8, 4424-4435, February 20, 1998
Determinants of DNA Binding and Bending by the
Saccharomyces cerevisiae High Mobility Group Protein NHP6A
That Are Important for Its Biological Activities
ROLE OF THE UNIQUE N TERMINUS AND PUTATIVE INTERCALATING
METHIONINE*
Yi-Meng
Yen §,
Ben
Wong ¶, and
Reid C.
Johnson **
From the Department of Biological Chemistry, UCLA
School of Medicine, Los Angeles, California 90095-1737 and the
Molecular Biology Institute, UCLA,
Los Angeles, California 90095
 |
ABSTRACT |
The non-histone proteins 6A/B (NHP6A/B) of
Saccharomyces cerevisiae are high mobility group proteins
that bind and severely bend DNA of mixed sequence. They exhibit high
affinity for linear DNA and even higher affinity for microcircular DNA.
The 16-amino acid basic segment located N-terminal to the high mobility
group domain is required for stable complex formation on both linear and microcircular DNA. Although mutants lacking the N terminus are able
to promote microcircle formation and Hin invertasome assembly at high
protein concentrations, they are unable to form stable complexes with
DNA, co-activate transcription, and complement the growth defect of
nhp6a/b mutants. A basic patch between amino acids 13 and 16 is critical for these activities, and a second basic patch
between residues 8 and 10 is required for the formation of monomeric
complexes with linear DNA. Mutational analysis suggests that proline 18 may direct the path of the N-terminal arm to facilitate DNA binding,
whereas the conserved proline at position 21, tyrosine 28, and
phenylalanine 31 function to maintain the tertiary structure of the
high mobility group domain. Methionine 29, which may intercalate into
DNA, is essential for NHP6A-induced microcircle formation of 75-bp but
not 98-bp fragments in vitro, and for full growth complementation of nhp6a/b mutants in
vivo.
 |
INTRODUCTION |
The high mobility group
(HMG)1 proteins are a family
of heterogeneous chromatin-associated DNA-binding proteins in
eukaryotic cells. They are the most abundant non-histone proteins found
in the nucleus and are divided into three classes: HMG-I/Y, HMG14/17, and HMG1/2 (1, 2). These proteins were classically recognized by their
high electrophoretic mobility in polyacrylamide gels and acid
solubility. The HMG-I/Y class of proteins function as accessory
transcription factors, whereas the HMG14/17 class are associated with
nucleosomes. The HMG1/2 class of proteins contain the HMG DNA binding
domain and are present at a level of about 1 copy/2-3 nucleosomes (3).
The HMG domain is a 70-80-amino acid region consisting mainly of
hydrophobic and charged residues with a few highly conserved aromatic
residues (4).
Members of the HMG1/2 class can be further divided into two subfamilies
based upon the number of HMG domains, their DNA sequence specificity,
and their evolutionary relationship (5). The sequence-specific HMG1/2
proteins contain a single HMG domain, which are usually restricted by
cell type and interact with relatively high affinity to a specific DNA
sequence. These proteins include the human sex-determining factor SRY
(6, 7), the lymphoid enhancer-binding factor LEF-1 (8), and the T-cell
factor TCF-1 (9). The other subfamily of HMG1/2 proteins are
ubiquitously expressed and bind to DNA with structural specificity but
little or no sequence specificity. One group of the
non-sequence-specific DNA-binding proteins contain multiple HMG domains
such as the abundant HMG1 and HMG2 proteins (10), human nucleolar
transcription factor hUBF (11), mitochondrial transcription factor
mTF-1 (12), and yeast ARS-binding protein ABF-2 (13). Other
non-sequence-specific HMG1/2 proteins found in yeast (14, 15),
plants (16), insects (17, 18), and protozoa (19, 20) contain only a
single HMG domain and, often, an accessory basic and/or acidic
domain.
The HMG domain of all these proteins probably fold into an L-shaped
region of three -helices, as shown by the NMR structures of rat HMG1
domain B, SRY, LEF-1, HMG1 domain A, HMG-D, and SOX4 (21-27). The
domain contains a primary hydrophobic core at the vertex of the
L-shaped structure formed by conserved aromatic residues from the three
-helices. The NMR structures of the two sequence-specific HMG
proteins, SRY and LEF-1, include their DNA recognition sequence (23,
24). These structures show the DNA to be greatly distorted in the
region of protein contact, with an overall bend of 80° and 120° for
SRY and LEF-1, respectively. The DNA is severely underwound, resulting
in a widened and shallow minor groove and a highly compressed major
groove. In conjunction with the helical underwinding, large positive
roll angles are induced by numerous DNA-protein contacts, which include
a partial intercalation of an amino acid side chain into the minor
groove of the DNA.
The sequence-specific HMG structures provide a basis for understanding
how the non-sequence-specific HMG1/2 proteins interact with high
specificity to distorted DNA containing bends, cruciforms, or DNA
kinked by cisplatin (28-32). Recently, it has been demonstrated that a
subgroup of non-sequence-specific HMG1/2 proteins, which contain only
one HMG box, can bind with higher affinity to linear DNA than HMG1/2
but exhibit only a modest preference for cruciform DNA (30, 33, 34). It
has become increasingly clear that the addition of basic amino acids to
a single minimal HMG box enhances the bending capacity and affinity for
DNA (24, 35-37). However, despite the fact that some of the
non-sequence-specific single HMG box proteins rival the DNA binding
affinities of sequence-specific proteins, the exact mode of DNA binding
by the non-sequence-specific HMG proteins has not yet been
determined.
The biological functions of HMG1/2-like proteins are just beginning to
be elucidated. They can function as architectural factors through their
ability to strongly distort DNA structures. In this regard, they have
been shown to promote assembly of specialized recombination complexes
derived from prokaryotic systems (38-40). HMG1/2 proteins and
their homologs can substitute for prokaryotic chromatin proteins to
condense DNA in vivo (33) and can facilitate nucleosome
assembly and disassembly in vitro (42-45). Moreover, efficient activated transcription of certain genes requires HMG proteins, which, in part, may be related to their ability to promote assembly of preinitiation complexes (41, 46). On the other hand,
some in vitro studies have found that HMG proteins inhibit transcription (47-49).
The yeast system provides a genetic tool to investigate the biological
roles of HMG proteins and to correlate in vitro activities with in vivo functions. A number of HMG box proteins have
been reported in Saccharomyces cerevisiae including the
non-histone proteins 6A/B (NHP6A/B) (14) and more recently the high
mobility group proteins HMO1/2 (15). NHP6A/B are closely related 11-kDa proteins that contain a single HMG box. The HMG box of NHP6A is 45%
identical to rat HMG1 box B and 80% identical to the HMG box of NHP6B
(Fig. 1A). NHP6A/B are unique in that they both contain a
highly basic amino acid region that precedes the HMG box. These proteins have a higher affinity for and bend DNA more efficiently than
mammalian HMG1/2 (33). In this report, we investigate the importance of
the N-terminal basic segment for high affinity DNA binding. Neither
NHP6A nor NHP6B is essential since nhp6A and nhp6B mutants grow normally, but the double mutant grows
slowly at 30 °C and is not viable at high temperatures. The
nhp6A/B mutants display a variety of morphological
changes and are defective in activated transcription of a subset of
genes (41, 50). We show in this paper that the N-terminal segment of
NHP6A is critical for its DNA binding activities and functional
properties. NHP6A mutants containing substitutions in other selected
regions have also been analyzed with respect to their in
vitro and in vivo properties.
 |
EXPERIMENTAL PROCEDURES |
Construction of NHP6A Mutants--
The NHP6A mutants were
constructed by direct cloning of PCR products using mutant
oligonucleotide primers or by site-directed mutagenesis using the
method of Kunkel (51). The sequence of the oligonucleotides used to
generate the mutations is given in Table I. In several cases (P21A,
M29A, and M29D), mutant PCR products were cloned by a three-way
ligation using internal restriction sites (Table
I). pRJ1228 (pET11a-NHP6A; Ref. 33) was
used as the template for PCR and the vector for reconstructing mutant NHP6A genes. pRJ1340 and pRJ1341 were generated by cloning into pBS
KS+ and pBS KS , respectively, a PCR product
obtained using a 5' NHP6A primer containing an
EcoRI/NdeI site and a 3' NHP6A primer containing a BamHI site. Single-stranded DNA for site-directed
mutagenesis was prepared from pRJ1340 and pRJ1341 using CJ236
(dut ung; Ref. 52). The mutant genes were subsequently
transferred using the NdeI and BamHI sites into
pET11a for protein overexpression. Each mutant gene was sequenced in
its entirety.
The NHP6A mutations were introduced into yeast as follows. The 300-bp
control region upstream of the NHP6A gene was obtained by PCR of
genomic S. cerevisiae DNA using primers containing
XhoI and NdeI sites engineered at the 5' and 3'
ends, respectively. After digestion with XhoI and
NdeI, the product was inserted into pRJ1340 to give pRJ1342,
which links the NHP6A promoter to the NHP6A gene flanked by
NdeI and BamHI restriction sites. This NHP6A region was then subcloned between the XhoI and
BamHI sites into pRS314 (TRP1 CEN6 ARSH4; Ref. 53) to create
pRJ1364. Different mutant NHP6A genes were substituted in place of the
wild-type gene using the unique NdeI and BamHI
sites. In addition, HMG1 box B and box B' were obtained by PCR of
pT7-RNHMG1 (54) with NdeI and BamHI engineered
ends. After digestion with NdeI and BamHI, these
products were ligated into pRJ1364, positioning them downstream of the
NHP6A promoter.
Protein Expression and Purification--
Recombinant proteins
were expressed from the pET11a-derivatives in RJ1878 (BL21 (DE3)
hupA::cm hupB::km; Ref. 33). NHP6A synthesis was induced for 3 h at 37 °C in LB when the cells
reached an A600 = 0.6 by the addition of 1 mM isopropyl-1-thio- -D-galactopyranoside. Two liters of cells were disrupted by sonication in 1/10 volume of 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM DTT, 1 mM EDTA, and 1 mM
phenylmethylsulfonyl fluoride. The extract was clarified by
centrifugation at 30,000 × g, and the NaCl
concentration was increased to 1 M. Polyethyleneimine
(Sigma) was added to 0.3%, and the nucleic acids were removed by
centrifugation at 20,000 × g. Residual
polyethyleneimine was removed by batch chromatography with 20% (v/v)
cellulose phosphate P-11 (Whatman), and the supernatant was dialyzed
overnight against 0.05 M buffer A (20 mM
Tris-HCl (pH 7.5), 1 mM DTT, 1 mM EDTA, 10%
glycerol, plus 0.05 M NaCl). The dialysate was passed
through a 4-ml S-Sepharose (Pharmacia) column equilibrated in the same
buffer, and the NHP6A protein was eluted in a 50-ml linear gradient
from 0.05 M to 1.0 M NaCl in buffer A. Fractions containing the NHP6A protein were pooled and subject to 2%
trichloroacetic acid precipitation at 0 °C for 30 min to remove
contaminating proteins. After centrifugation for 30 min at 30,000 × g, the supernatant was adjusted to 10% trichloroacetic
acid, and the homogeneous NHP6A was recovered by centrifugation as
before. The precipitate was washed with acetone, dried briefly,
resuspended in buffer B (20 mM HEPES (pH 7.5), 0.1 M NaCl, 1 mM DTT, 1 mM EDTA, and
50% glycerol) and dialyzed overnight in the same buffer. Wagner
et al. (55) reported that trichloroacetic acid precipitation
affected DNA binding by HMG1, but we have been unable to detect any
difference between NHP6A purified using trichloroacetic acid
precipitation or under entirely native conditions using multiple
chromatography steps. Proteins concentrations were quantitated by laser
densitometry (Molecular Dynamics) of SDS-polyacrylamide gels stained
with Coomassie Blue using a titration of lysozyme as a standard. Values
obtained were within 1-3% of the amounts determined by quantitative
amino acid analysis (UCLA Protein Microsequencing Facility).
Gel Mobility Shift, Ligase-mediated Circularization, and Hin DNA
Inversion Assays--
Labeled DNA fragments for gel mobility shift and
ligation assays were obtained using PCR reactions containing
[ -32P]dATP and pRJ551-44, pRJ551-66, or pRJ551-76
as described (38, 56). After digestion with EcoRI, fragments
of lengths 66, 75, and 98 bp containing EcoRI cohesive ends,
respectively, were purified in 10% polyacrylamide gels. Circular DNA
was formed from reactions containing 8 ng of linear fragment, 40 ng of
NHP6A, and 20 units of T4 ligase that were incubated at
30 °C for 1 h under the conditions described previously (33).
The products were then digested with 100 units of exonuclease III for
60 min, extracted with phenol/chloroform (1:1, v/v) and precipitated
with ethanol resulting in >90% monomer circle. Gel mobility shift and
ligase-mediated circularization assays were performed as described in
Ref. 33 and electrophoresed on 6% polyacrylamide gels (29:1
acrylamide:bisacrylamide). Hin-catalyzed DNA inversion reactions were
performed as described previously using pMS551-83, which contains 83 bp between the centers of hixL1 and the proximal Fis binding
site in the enhancer (56).
Stoichiometry of NHP6A-DNA Complexes--
NHP6A-HMK, containing
the heart muscle kinase recognition sequence (RRASV) fused to the
C-terminal end of NHP6A, behaved identically to the wild-type in DNA
binding assays (data not shown). 10 µg of NHP6A-HMK was labeled by
incubating with 5 units of bovine heart muscle kinase (Sigma) and 50 µCi of [ -32P]ATP (>6000 mCi/mmol; Andotek) in 20 mM HEPES (pH 7.5), 100 mM NaCl, and 12 mM MgCl2 for 1 h at 37 °C. The reaction
was quenched with 10 mM EDTA, precipitated with
trichloroacetic acid as described above, and the
32P-labeled NHP6A-HMK was resuspended in buffer B. The
specific activity of the protein under potential gel quenching
conditions was determined by polymerizing a known amount in a 6%
polyacrylamide gel plug (29:1
acrylamide:N,N-bisacryloylcystamine; Sigma). The plug was
incubated with 50 mM -mercaptoethanol for 30 min at 50 °C to dissolve the disulfide cross-links and counted in
scintillation fluid (EcoSint; National Diagnostics). 98-bp DNA
fragments were prepared as described above. The DNA concentration was
determined by a Hoefer TK100 fluorometer using Hoechst dye 33258 (Sigma) and by quantitation (ImageQuant, Molecular Dynamics) of digital images of ethidium bromide-stained polyacrylamide gels in which an
aliquot of the fragment was electrophoresed together with varying concentrations of pBR322 digested with HaeIII. Both methods
gave the same results. Gel mobility shift assays were performed as described above, except that electrophoresis was in 6% 29:1
acrylamide:N,N-bisacryloylcystamine gels. The gels were
stained with SybrGreen (Molecular Probes) and visualized with a Hitachi
FMBIO II Fluorimager. The first and second complex bands were excised,
the gel slice dissolved with -mercaptoethanol as described above,
and counted in scintillation fluid. The molar amount of protein in each
complex was calculated from its specific activity; the molar amount of
DNA was determined by comparison to varying amounts of the DNA fragment
electrophoresed on the same gel.
Generation Times, NHP6A Expression Levels, and in Vivo CUP1
Transcription Assays--
The wild-type and NHP6A mutant genes
contained on pRS314 were transformed into RJY6012 (MAT
ura3-52 leu2-3, 112 his3 200 trp1- 201 lys2-801 suc2- 9
gal3 nhp6A:: ura3 nhp6B::LEU2) by the lithium
acetate method (57). The transformants were streaked once on selective
media (SD minus His or Trp; Ref. 57) and inoculated into liquid
selective media. Growth was monitored at A600,
and the doubling time in log phase at 30 °C was determined in
duplicate for two individual transformants.
For quantitation of NHP6A levels, transformants were grown in 25 ml of
liquid selective media until the A600 was 1.0. The cells were washed with distilled water and resuspended in 5 ml of
50 mM sodium phosphate buffer (pH 7.0) and 1 mM
phenylmethylsulfonyl fluoride. The yeast were lysed by passing the
mixture three times through a French press. After a brief incubation at
100 °C, the extract was cleared by centrifugation at 30,000 × g for 30 min. 200 µg of total protein was trichloroacetic
acid-precipitated and electrophoresed on a 15% SDS-polyacrylamide gel.
The gel was immunoblotted with anti-NHP6A (41) and
anti-glucose-6-phosphate dehydrogenase (Sigma) as a loading
control.
CUP1 transcription was assayed in RJY6024 (RJY6012 + pL 3D241
containing the CUP1-lacZ reporter; Refs. 41 and 58). At least 2-4 transformants were grown in SD media under selective conditions for 2-4 days and then subcultured into fresh selective media and grown for 6 h. 1 mM CuSO4 was
then added, and -galactosidase activity measured after an additional
2 h at 30 °C in which the final culture
A600 was 0.5-1.0.
In Vitro Transcription--
Transcription reactions (25 µl)
were performed using 130 µg of yeast nuclear extracts in the presence
of the acidic activator GAL4- VP4, NHP6A, and 100 ng of
G5E4T as the DNA template. mRNA levels were
detected by primer extension. Reaction conditions, GAL4- VP4, and
G5E4T have been described previously (41,
59).
Physical Properties--
Circular dichroism spectra from 190 to
240 nm was measured with an AVIV 62ADS circular dichroism
spectrophotometer with 20 iterations at 25 °C. Proteins were
dialyzed into 10 mM sodium phosphate buffer (pH 7.4) and
protein concentrations determined as above. Secondary structure
characteristics were calculated by the self-consistent method using
DICROPROT (60).2 Thermal
denaturation curves were obtained under the same conditions at 222 nm.
The temperature was varied from 10-90 °C with an incubation time of
5 min for every 5 °C.
 |
RESULTS |
DNA Binding Properties of Wild-type NHP6A
NHP6A forms stable complexes on DNA of varying sequences as
revealed by polyacrylamide gel electrophoresis (Fig. 2A;
Ref. 33). With increasing concentrations of NHP6A, a discrete set of
higher order complexes are obtained. 32P-Labeled NHP6A was
used to determine the stoichiometry of binding in the first and second
complexes formed on a 98-bp DNA fragment as described under
"Experimental Procedures." Quantitation of four to eight
individual NHP6A-DNA complexes from separate experiments gave average
molar ratios of 0.92 ± 0.2 for the first retarded complex and
2.2 ± 0.4 for the second complex. Therefore, NHP6A binds to DNA
as a monomer in a stepwise manner. The binding constant (KD) for the initial complex is 100 nM,
a value that is constant on DNA of different sequences and lengths
(23-300 bp).
The ability of NHP6A to bend DNA is most directly demonstrated by
ligase-mediated circularization assays where the wild-type protein can
form up to 70% monomer circles on DNA substrates as short as 66 bp
(33). By measuring the amount of wild-type NHP6A required to generate
the half-maximum yield of 98-bp circles, we calculate a
Kcircle of 1.5 × 10 8
M (Fig. 3B). NHP6A binds much more tightly to
curved DNA of mixed sequence than to linear DNA. This is shown in Fig.
4A where binding to a 98-bp microcircle was assayed by
polyacrylamide gel electrophoresis. Two discrete complexes are formed
at low concentrations of NHP6A, followed by the formation of higher
order species with increasing protein concentrations. Gel mobility
shift assays on 75-bp microcircles also generates two high affinity
complexes, but three high affinity complexes are formed on 66-bp
microcircles (Fig. 4, F and G). The number of
high affinity complexes were identical regardless of whether NHP6A was
added to purified microcircles or whether the products of the NHP6A + DNA ligase reactions used to generate the microcircles were directly
analyzed by native gel electrophoresis (data not shown). The binding
constant for these curved DNA molecules is ~1.5 nM.
Binding to the pre-bent substrates is extremely stable, as revealed by
the resistance of NHP6A-microcircle DNA complexes to added competitor
DNA (Fig. 4H). The addition of 2.5 mg/ml salmon sperm DNA
(corresponding to a 2,500,000:1 w/w ratio of competitor to
microcircular DNA) was unable to remove NHP6A from the two high
affinity sites on the 98-bp microcircle, but 5.0 µg/ml (500:1 w/w
ratio of competitor to linear DNA) was sufficient to dissociate most of
the prebound NHP6A from a linear substrate.
The N Terminus Is Necessary for Efficient Binding and Bending of
DNA
The 94-amino acid NHP6A protein contains a 16-amino acid region
located N-terminal to the minimal HMG domain. This segment contains two
blocks of basic residues: KKR between residues 8 and 10 and RKKK
between 13 and 16 (Fig. 1). To determine
the importance of these amino acids for DNA binding and NHP6A function,
three different truncations of NHP6A were constructed: a deletion of the entire N terminus (2-16), a deletion that removed the first block of basic residues (2-12), and a deletion that retains both blocks of basic residues (2-7).

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 1.
HMG domain proteins. A, sequence
alignment of five non-sequence-specific HMG box domain proteins and two
site-specific HMG box proteins based upon homology model building (76).
The position of the three -helices that constitute the HMG box B domain is shown above the sequences (25, 26). The numbering scheme at
the top of the figure refers to amino acid positions within
NHP6A. B, mutations of NHP6A. C, 15%
SDS-polyacrylamide gel electrophoresis of recombinant NHP6A proteins:
wild-type (lane 1), (2-7) (lane 2),
(2-12) (lane 3), (2-16) (lane 4), P18A (lane 5), P21A (lane 6), P18A/P21A (lane
7), M29A (lane 8), F30V (lane 9), and F31V
(lane 10).
|
|
Deletion of the entire N terminus of NHP6A abolished the high affinity
of the protein for linear DNA with no distinct DNA-protein complexes
being formed (Fig. 2D). We
estimate that this mutant binds approximately 600-fold poorer than
wild-type protein by gel mobility shift assays. This resembles the low
affinity association of HMG1 to linear DNA observed under similar assay
conditions (29, 33, 61). NHP6A (2-16) also bound poorly to
microcircles (Fig. 4C). This unstable DNA association by the
minimal HMG box of NHP6A represents a functional HMG interaction and
not a nonspecific association since (2-16) was able to induce
microcircle formation. As shown in Fig.
3A, NHP6A (2-16) converted
40% of a 98-bp DNA fragment into monomer circles; however, the amount
of protein required was about 300-fold higher than for the wild-type
protein (Table II). These results
demonstrate that the basic N-terminal tail of NHP6A performs a critical
function in stable DNA binding, although a weak functional association
with DNA is possible with only the minimal HMG box.

View larger version (71K):
[in this window]
[in a new window]
|
Fig. 2.
Comparison of DNA binding by NHP6A and NHP6A
mutants in gel mobility shift assays. A, a
32P-labeled 98-bp linear DNA fragment incubated in 20 µl
of buffer alone, or with 2-fold increasing amounts of wild-type NHP6A
as labeled at the top. B-J, the same fragment
incubated with increasing amounts of mutant NHP6A proteins as denoted
for each panel.
|
|

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 3.
Circularization of DNA fragments with NHP6A
wild-type and mutants in ligation assays. A, a
32P-labeled 98-bp linear fragment with EcoRI
ends was incubated with buffer alone (lane 1), NHP6A
(lane 4), or NHP6A (2-16) (lanes 5-15) and
T4 DNA ligase for 10 min (lanes 2-15).
DNA-protein molar ratios were 40:1 for NHP6A and ranged from 40:1 to
40,960:1 increasing by 2-fold increments for NHP6A (2-16).
Exonuclease III was added to reactions in lanes 3-15, so
the products that remain represent circular species only. B,
NHP6A (lanes 1-4), NHP6A (2-12) (lanes 5-8), and NHP6A P21A (lanes 9-12) all ranging from
20:1 to 160:1 increasing by 2-fold increments were added to identical
ligation reaction conditions as in A. NHP6A F31V
(lanes 13-16) ranging from 320:1 to 2560:1 was used.
C, NHP6A M29A (lanes 1-4) was added to a 98-bp
DNA fragment at molar ratios 20:1 to 160:1 increasing by 2-fold
increments. In lanes 5-10, a 75-bp fragment with
EcoRI ends was incubated: lane 5, NHP6A at 80:1;
lanes 6-10, M29A ranging from 16:1 to 160,000:1, increasing
by 10-fold increments.
|
|
In contrast to the properties of the deletion of the entire 16-amino
acid N terminus, a deletion of the first 12 amino acids resulted in a
mutant that retained relatively high affinity binding, although it was
not capable of producing discrete DNA complexes on polyacrylamide gels
(Fig. 2C and Table II). Therefore, we conclude that the RKKK
motif between residues 13 and 16, which are retained in this mutant, is
the critical determinant within the N terminus for mediating high
affinity DNA association. Although NHP6A (2-12) did not form
individual complexes on linear DNA, it bound to 98-bp microcircles with
similar affinity as the wild-type (Fig.
4B). In addition, the ability
of (2-12) to form 98-bp microcircles was indistinguishable from
wild-type (Fig. 3B).

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 4.
Gel mobility shift assays on
32P-microcircle DNA. A, 32P-labeled
98-bp microcircles were incubated with buffer alone or NHP6A.
B, NHP6A (2-12) protein. C, NHP6A (2-16).
D, NHP6A P18A/P21A. E, NHP6A F31V. F,
a 66-bp microcircle was incubated with buffer alone or NHP6A.
G, a 75-bp microcircle incubated with buffer alone or NHP6A.
H, competition assays. In lanes 1-5, a 98-bp
linear fragment incubated with buffer alone (lane 1) or 32 ng of NHP6A (lanes 2-5) for 20 min, in which 10-1000 ng of
salmon sperm competitor DNA was added in 10-fold increments
(lanes 3-5) and the samples loaded after 10 min. In
lanes 6-10, 98-bp microcircles were incubated with buffer
alone (lane 6) or 1 ng of NHP6A (lanes 7-10) for
20 min. 10, 20, and 50 µg of competitor DNA were then added
(lanes 8-10) and the sample loaded after 30 min.
|
|
NHP6A (2-7) retains both blocks of basic amino acids in the N
terminus and exhibited completely normal DNA binding, including the
formation of stable complexes on linear DNA (Fig. 2B), and the formation and binding of DNA microcircles (Table II). Therefore, no
role in DNA binding is detectable for residues 2-6. The difference in
binding properties on linear DNA between (2-7) and (2-12) suggest that the KKR motif between residues 8 and 10 functions to
stabilize binding of individual protomers of NHP6A to DNA, but it is
clearly not critical for productive DNA interactions.
Circular dichroism was used to assess the folding of wild-type NHP6A as
compared with the N-terminal deletion mutant (Fig. 5A). According to the
self-consistent method of Sreerama and Woody (62), wild-type NHP6A was
predicted to contain 49% -helix, <1% -sheet, 22% turn, and
19% other structure. These values are slightly lower than the amount
of -helical structure predicted by circular dichroism data on HMG1
box B (31, 37, 63), although the C-terminal extension of box B was not
included in their spectra. The spectrum of the NHP6A 2-16 mutant
(Fig. 5A) showed that it was highly structured with
approximately 67% -helix, <1% -sheet, 13% turn, and 11%
other structure. These values are similar to the 75% estimate of
-helical content derived from NMR data on the minimal HMG1 box B
(25, 26) and the HMG-D box (22). The increase in -helical content in
the NHP6A N-terminal deletion mutant as compared with wild-type is
consistent with the N-terminal 16 amino acids of NHP6A being
unstructured in solution. In addition, the Tm of
wild-type and NHP6A 2-16 were both found to be 39 °C (Fig.
5D), further indicating that the N terminus does not play a
role in stabilizing the overall structure.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Physical properties of NHP6A. A,
CD spectra at 25 °C of wild-type and mutant NHP6A: wild-type
(a) and NHP6A (2-16) (b). B, CD
spectra at 25 °C of NHP6A (a), NHP6A P18A (b),
NHP6A P21A (c), and NHP6A P18A/P21A (d).
C, CD spectra at 25 °C of NHP6A (a), NHP6A
Y28D (b), NHP6A M29A (c), and NHP6A F31V
(d). D, thermal denaturation of wild-type
(solid line) and NHP6A (2-16) (dotted line)
as monitored by CD at 222 nm.
|
|
Importance of Prolines at Position 18 and 21 for DNA Binding by
NHP6A
NHP6A contains two prolines (positions 18 and 21) that are located
within the N-terminal end of the HMG domain. The proline at position 21 of NHP6A, which shows remarkable conservation among all
non-sequence-specific HMG1/2 proteins (4, 5), stabilizes a secondary
hydrophobic core that associates the N- and C-terminal ends of the HMG
domain (22). In LEF-1, proline 66, located at the C-terminal end of the
HMG domain, appears to be important in directing its C-terminal basic
extension that is essential for high affinity LEF-1-DNA binding (24).
To determine whether the N-terminal prolines in the NHP6A HMG domain
may be performing analogous roles, we created alanine substitutions at
these positions and analyzed their DNA binding and folding
properties.
NHP6A P18A displayed a 2.5-fold reduction in affinity for linear DNA
whereas NHP6A P21A showed 4-fold reduced affinity (Fig. 2, E
and F). The behavior of the double mutant P18A/P21A was
identical to that of P21A (Fig. 2G). Binding to
microcircular DNA was similarly reduced with a KD of
4 nM for P18A and 20 nM for both P21A and
P18A/P21A (Fig. 4D). All three mutants were able to convert 70% of 98-bp linear DNA fragments into circles, although P18A required
2 times more protein than wild-type and both P21A and P18A/P21A
required 4-fold more protein (Fig. 3B, Table II). Thus, the
prolines at position 18 and 21 play a modest role in DNA binding.
CD analysis of the proline mutants indicated that P18A is folded
identically to wild-type, whereas the P21A and the double mutant
P18A/P21A displays a small (<10%) reduction in -helical content
compared with wild-type (Fig. 5). Proline 21, therefore, contributes
to the folding of the NHP6A HMG domain probably via hydrophobic
interactions with residues of -helix III (see
Discussion). Proline 18 may facilitate positioning of the
basic N-terminal segment upon DNA binding as also elaborated in the
Discussion.
Importance of an Intercalating Side Chain for DNA Binding by
NHP6A
DNA binding and bending by either LEF-1 or SRY is facilitated by a
hydrophobic amino acid located near the N terminus of helix 1 that
intercalates between base pairs via the minor groove (23, 24).
Alignment of amino acid sequences as in Fig. 1 suggests that
methionine 29 of NHP6A would be in the correct position to function as
an intercalating side chain. To test whether methionine 29 of NHP6A is
important for DNA binding, this residue was mutated to alanine.
Surprisingly, M29A did not show any difference in its affinity to
linear DNA as compared with wild-type (Fig. 2). Even changing
methionine 29 into a negatively charged aspartic acid resulted in less
than a two-fold reduction affinity to linear DNA. Both M29A and M29D
bound to 98-bp microcircles with a KD of 2.5 nM and formed 98-bp circles with similar efficiency as wild-type NHP6A (Fig. 3).
The relatively modest effect on DNA binding by substitutions at
position 29 led us to test whether adjacent amino acids could function
in this capacity. Tyr-28, Phe-30, and Phe-31 were changed to valine or
aspartic acid. F30V exhibited very little difference in affinity for
linear DNA and 98-bp microcircles compared with wild-type and did not
differ in its DNA bending properties. Y28D and F31D were strongly
defective in binding to linear and circular DNA, but we show below that
they are unfolded in solution. F31V was able to bind poorly to both
linear DNA and microcircles (Figs. 2 & 4E); however, the ability to
form microcircles was greatly reduced with a maximum of only 4% of the
input DNA ligated into 98-bp circles when very high amounts of protein
were added (Fig. 3).
CD analysis demonstrated that Y28D and F31V were largely unfolded in
solution, whereas M29A showed only a slight change in CD profile (Fig.
5C). The CD data, combined with the known HMG box
structures, suggest that the Phe-31 and Tyr-28 side chains are oriented
such that they are contributing to the primary hydrophobic core that
stabilizes the HMG fold (22, 64). Since F31V forms complexes with DNA
microcircles, interaction with the pre-bent DNA ligand is presumably
stabilizing its folded structure. The HMG box structure in F31D,
however, is probably completely disrupted since it is not capable of
forming complexes with curved DNA.
The lack of any clear effect on DNA interactions by M29A, M29D, or F30V
revealed by the previous assays led us to test these mutants for their
ability to circularize 75-bp fragments. The formation of 75-bp
microcircles are predicted to require the greatest amount of DNA
bending per bound NHP6A protomer (see "Discussion"). In this assay,
a clear difference between wild-type and M29A or M29D was observed
(Fig. 3C). Neither M29A nor M29D was able to form 75-bp
microcircles, even at very high concentrations of added protein. F30V
was fully functional for 75-bp microcircle formation. Taken together,
we conclude that Met-29 does play a role in NHP6A-induced DNA bending,
but this is only revealed by assays that demand DNA bending near the
maximum possible extent possible for wild-type NHP6A.
Ability of the NHP6A Mutants to Function in Biological
Reactions
Growth Phenotypes--
Using Saccharomyces cerevisiae,
we are able to correlate the in vitro properties of DNA
binding by NHP6A mutants to their biological functions. The double
knockout mutant ( nhp6a/b-RJY6012) exhibits a slow growth
phenotype forming colonies of heterogeneous size, which are
temperature- and cold-sensitive at 38 °C and 23 °C, respectively
(33, 50). A yeast CEN shuttle vector containing the endogenous NHP6A
promoter was used to express NHP6A and various mutants in the
nhp6a/b cells. Western blotting confirmed that episomal
expression of NHP6A and most NHP6A mutants were similar to endogenous
levels of chromosomal expression (Table
III). The exceptions were Y28D and F31V,
which are unfolded in solution and were present at <10% of wild-type
levels. Interestingly, (2-12) was present at 70% the level of
wild-type whereas (2-16) was present at <20% of the wild-type
level despite normal in vitro folding. The presence of
episomal NHP6A and all of the above mutants except for (2-16), Y28D
and F31V were able to reverse the temperature and cold sensitivity of
nhp6a/b cells (data not shown).
The generation time of the nhp6a/b cells during log phase
is approximately 250 min, nearly 2.5 times slower than the NHP6A/B parent (Table III). The expression of normal NHP6A protein in RJY6012 restored the generation time of these cells to a near wild-type 130 min. The presence of (2-16) had little stimulatory effect on the
growth of the nhp6a/b mutant, but this may be primarily due to its low steady state expression levels. (2-7), (2-12), P18A, and F30V restored near normal growth rates, as expected from
their in vitro properties. NHP6A M29A only partially rescued growth rates of nhp6a/b cells (190 min generation time),
even though this mutant has normal in vitro DNA binding
properties in most regards. nhp6a/b cells expressing P21A
and P18A/P21A, which have a disruption of the secondary hydrophobic
core, also grew significantly slower (175-180 min generation time).
The addition of Y28D or F31V had no stimulatory effect on
nhp6a/b cell growth, but as noted above, steady state
levels of these proteins are very low.
HMG1 box B' is able to efficiently complement the growth phenotype of
nhp6a/b mutants (RJY6398, Table III), demonstrating the
in vivo functional relationship between these homologous
proteins. Significantly, HMG box B also requires a basic region to be
active in vivo since the minimal HMG box B has no
stimulatory effect on growth (RJY6271, Table III).
Activated Transcription at the CUP1 Locus in Vivo--
The NHP6A
mutants were also tested for their ability to specifically enhance
activated transcription of the CUP1 promoter, one of a subset of genes
whose activated expression is facilitated by the NHP6A/B proteins (41).
Following 2 h of exposure to 1 mM CuSO4 in
minimal media, -galactosidase activity from a CUP1-lacZ reporter
construct was induced 40-fold in nhp6a/b cells expressing NHP6A from pRJ1342, similar to the 47-fold induction measured in
wild-type cells (Fig. 6A). The
induced level of CUP1-LacZ expression in the nhp6a/b
mutant cells was only 8-fold above basal level. Activated transcription
of the CUP1 promoter by the different NHP6A mutants largely paralleled
their effect on growth. (2-16) had no activity, whereas (2-12)
displayed essentially wild-type CUP1 expression levels. CUP1
transcription in the presence of M29A was also notably reduced.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of NHP6A mutants in
transcription. A, Activated transcription at CUP1 in
vivo. Levels represent -fold induction of -galactosidase at the
CUP1 locus following 2.5 h with CuSO4. Values
represent the average and standard deviation obtained from two to four
individual transformants. B, in vitro
transcription reactions on the G5E4T template
were performed using yeast nuclear extract supplemented with NHP6A in
the absence (lanes 1-4) or presence of 146 ng of
GAL4- VP4 (lanes 5-8). C, in vitro
transcription reactions with 1 µg of NHP6A, various mutants or
purified calf-thymus HMG2 (lanes 2-10). Basal (lane
1) indicates no activator or NHP6A added.
|
|
Stimulation of in Vitro Transcription--
The
G5E4T template containing five GAL4 binding
sites upstream of the adenoviral E4T promoter was used as a
model substrate to test the ability of the mutants to facilitate
activated transcription in vitro. Transcription in yeast
nuclear extracts activated by GAL4- VP4 was stimulated 2-5-fold by
increasing amounts of exogenous NHP6A (Fig. 6B). A similar
increase in transcript levels was observed by the addition of bovine
HMG1 or HMG2 (Fig. 6C), but HU, an unrelated Escherichia coli DNA bending protein, had no effect on this
reaction (data not shown). NHP6A (Fig. 6B) or HMG1/2 (data
not shown) had no effect on basal transcription from this promoter,
similar to that observed for the GAL1 promoter (41).
Most of the mutants stimulated transcription at
G5E4T to a similar extent as wild-type (Fig.
6C and data not shown). NHP6A (2-16) was completely
defective even when large amounts of protein (>2 µg) were added, but
(2-12) behaved indistinguishably from wild-type. Transcription in
the presence of M29A approached wild-type levels, but was significantly
reduced in the presence of M29D. As expected, the unfolded mutants Y28D
and F31V had little or no stimulatory activity.
Hin-catalyzed Site-specific DNA Inversion--
When the
recombinational enhancer is located within 100 bp of a recombination
site, HU or an HMG1/2 protein is needed to assemble the catalytically
competent invertasome (33, 38, 56). In this reaction, the auxiliary DNA
bending protein is believed to function strictly as a DNA architectural
factor to facilitate DNA looping of the enhancer segment. In Fig.
7A, the amount of NHP6A mutant
added to the DNA inversion reaction was adjusted to compensate for
defects in DNA binding. Under these conditions, all the mutants are
able to stimulate invertasome assembly with the exception of the
unfolded proteins Y28D and F31V, which bind and bend DNA poorly at all
tested concentrations. NHP6A (2-16) displayed surprisingly high
activity in this assay (Fig. 7B), particularly in comparison
to its complete inactivity in stimulating transcription in
vitro. The proficiency of (2-16) in promoting invertasome
formation at moderately high concentrations of protein probably
reflects its ability to promote microcircle formation at very high
protein concentrations.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of NHP6A mutants on assembly of
activated Hin invertasomes. A, cleavage reactions on the DNA
substrate pMS551-83 in the presence of wild-type and NHP6A mutants,
electrophoresed in a 1% agarose gel. Lane 1 contains no
Hin, lane 2 contains the E. coli protein HU,
lane 3 contains no accessory protein, lane 4 contains NHP6A, lane 5 contains (2-7), lane 6 contains P18A, lane 7 contains P21A, lane 8 contains P18A/P21A, lane 9 contains M29D, lane 10 contains F30V, lane 11 contains Y28D, and lane 12 contains F31V. B, lane 1 contains NHP6A, and
lanes 2-5 contain (2-12). C, lanes
1-4 contain (2-16). The positions of the products of the Hin
cleavage assay: linearized plasmid (lin: single
hix site cut), excised vector (vec: two
hix sites cut), and excised invertible segment
(invert) as well as the open circular plasmid (OC) and supercoiled plasmid (SC) are
indicated.
|
|
 |
DISCUSSION |
DNA Binding and Bending by Wild-type NHP6A--
NHP6A is a member
of a subclass of HMG1/2 proteins that contain a single HMG box and bind
nonspecifically to linear DNA with relatively high affinity. NHP6A
binds equivalently to DNA varying in sequence and length and forms
distinct complexes upon polyacrylamide electrophoresis with a
KD of 100 nM. We show in this report
that each complex represents a monomer of NHP6A bound to DNA. Although
the complexes formed on linear DNA are stable during long term
electrophoresis in a gel matrix, they readily dissociate in the
presence of excess DNA. NHP6A binds with >50-fold higher affinity to
microcircular DNA. The complexes formed on microcircular DNA are
extremely stable; NHP6A remains bound to the microcircles in the
presence of 1000-fold excess linear DNA. Preferential binding to
microcircular DNA has also been reported for HMG1 and HMG-D (30, 65).
Even though NHP6A binding is presumably targeted to the distorted
structures present on microcircular DNA, it does not bind
preferentially to four-way junctions (data not shown). High affinity
binding to four-way junctions is a feature of many HMG proteins,
although the related HMG-D and cHMG1a proteins also do not display this
property (17, 66).
The formation of stable complexes of defined numbers of NHP6A protomers
on microcircular DNA of varying lengths can be used to estimate the
degree of DNA bending introduced upon NHP6A binding. The measured
persistence length of DNA (67) gives an average intrinsic flexibility
of about 2.4°/bp (360°/150 bp). Thus, DNA lengths of 66, 75, and 98 bp can generate 158°, 180°, and 235° of curvature. Based on the
number of NHP6A protomers bound to preformed microcircles (Fig. 3) or
upon formation of microcircles (data not shown) of lengths 98 bp (two
complexes), a 75 bp (two complexes), or 66 bp (three complexes), the
minimal amount of protein-induced bending can be calculated. To create
a 98-bp microcircle, each of the two NHP6A-induced bends required to
complete the DNA circle would be approximately 60°, which corresponds
to a 120° DNA bending angle by each NHP6A protomer relative to linear
DNA. A 75-bp microcircle requires a 45° bend in the DNA from each of the two bound NHP6A protomers resulting in a 135° bending angle. Since the 66-bp microcircle has three bound NHP6A protomers, an equilateral triangle can be used to estimate the induced bending of the
DNA to be 60°, which corresponds to a bending angle of 120°.
Therefore, from these experiments we estimate NHP6A induces bend angles
between 120 and 135°. These values are in the range of the angles
observed with LEF-1 by NMR (120°; Ref. 24) and cHMG1a by fluorescence
resonance energy transfer (150°; Ref. 68). However, they are greater
than the 80° observed in the SRY-DNA complex by NMR (23), or the
60° estimated for DNA binding by HMG-D by a ligase-mediated
circularization assay (30).
High Affinity DNA Binding by NHP6A Requires Its Unique N
Terminus--
The 16-amino acid segment located N-terminal of the
minimal HMG domain of NHP6A is essential for its unusually stable DNA interaction. Removal of this region abolishes the ability of the protein to form discrete complexes on both linear and microcircular DNA
and eliminates most of its biological activities. The remaining minimal
HMG box is capable of poorly binding to DNA in vitro, as
evidenced by its ability to form microcircles, promote Hin invertasome
formation, and induce DNA supercoiling in the presence of topoisomerase
I (data not shown) at high protein concentrations. These activities
provide strong evidence that the minimal HMG box remains capable of an
authentic, albeit weak, HMG-DNA interaction. Circular dichroism and
thermal stability data indicate that the N-terminal segment is
unstructured in solution and has no effect on the integrity of the
folded HMG domain. Upon NHP6A-DNA interaction, the basic N-terminal arm
presumably associates with the DNA to anchor the complex. We imagine
that the N-terminal arm may cross over the phosphate backbone and
protrude into the major groove (Fig.
8A), as does the C-terminal
arm of LEF-1 (24), or possibly continue along the minor groove as
schematically drawn in Fig. 8B.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 8.
Schematic models of NHP6A-DNA complexes.
A, mode of DNA binding with the N-terminal arm inserted
within the major groove. B, the N-terminal arm bound along
the minor groove. The predicted locations of amino acids within the HMG
fold and the 16-amino acid N-terminal segment that are discussed in the
paper are denoted.
|
|
There are two blocks of basic amino acids within the NHP6A N-terminal
segment, block 1 between residues 8 and 10 (KKR) and block 2 between
residues 13 and 16 (RKKK). Both play a role in stabilizing DNA binding,
but block 2 is of primary importance. A deletion, NHP6A (2-12),
that removes patch 1 but retains patch 2 binds linear DNA and promotes
microcircle formation almost as well as wild-type, although it does not
form stable monomeric complexes on linear DNA by gel mobility shift
assays. The deficiency in stable complex formation on linear, but not
microcircular DNA, does not seem to affect any of its biological
activities that were measured. The first 7 amino acids of the
N-terminal arm play no detectable role in DNA binding or biological
properties of NHP6A.
We find it significant that NHP6A (2-16) is not capable of
potentiating transcription in vitro, even in reactions
containing a large excess of protein. Moreover, this mutant was unable
to form promoter complexes together with TBP and TFIIA, unlike
wild-type NHP6A or the NHP6A (2-12) mutant (Ref. 41; data not
shown). By contrast, NHP6A (2-16) is still able to promote Hin
invertasome assembly at moderately high concentrations. These
differences may indicate that the NHP6A protein is performing a
specific function in transcription rather than functioning merely in an
architectural role, as is probably the case for the recombination
reaction.
Steady state cellular levels of NHP6A (2-16) are <20% of
wild-type. This difference suggests that the mutant protein may be
rapidly turned over in the yeast cells even though it is well structured. The apparent instability of NHP6A (2-16) could be due
to its weak DNA binding properties that result in poor nuclear retention and thereby rapid degradation. A lack of retention in the
nucleus may also result from the removal of a nuclear localization signal (NLS) present in the N-terminal arm. The amino acid sequence of
NHP6A between amino acids 8 and 16 (KKRTTRKKK) matches an NLS motif
(69). Other NLS sequences have been identified in the HMG domain of
mUBF, SRY, SOX9, and LEF-1 (70-73). Cellular levels of NHP6A
(2-12) are also reduced to about 70% of wild-type, but NHP6A
(2-7) levels are normal. This provides further support for the
importance of residues 8-16 for protein stability, and implies that
the residues between 13 and 16 are more important than the residues
between 7 and 12. Further experiments will be needed to confirm that
the basic N terminus contains a nuclear localization signal in addition
to being required for high affinity DNA binding.
Other HMG proteins also require a basic region adjacent to the HMG
domain. Teo et al. (37) could not form microcircles with HMG1 box A or B but could form them with box B', which contains a patch
of basic amino acids at its C terminus. This observation is likely to
be related to our finding that HMG1 box B' is able to largely
complement the growth defect of nhp6A/B mutants, whereas HMG box B is ineffective (although an NLS in the box B' basic region
may also contribute to this difference). HMG-D also contains a
positively charged patch of amino acids at the C-terminal end of its
HMG domain, which are required for efficient DNA binding on linear DNA
in vitro (30). However, in contrast to the NHP6A (2-16)
mutant, the minimal HMG-D domain can form stable complexes on
microcircles. A short basic patch adjacent to the C terminus of LEF-1
was found to be required for high affinity and bending by this
sequence-specific HMG protein (36).
Role of Prolines at the N Terminus of the NHP6A HMG
Domain--
NHP6A contains two prolines at positions 18 and 21, which
are predicted to be located near the top of the L-shaped HMG domain adjacent to the N-terminal arm (see Fig. 8) based upon the structures of box A and B from HMG1 (21, 22, 25, 26). When proline 18 in NHP6A was
changed to an alanine, a 2-3-fold decrease in DNA binding to linear
and microcircular DNA was measured. CD analysis did not reveal a
significant difference between wild-type NHP6A and NHP6A P18A. We
postulate that proline 18 may direct the peptide backbone to facilitate
positioning of the N-terminal arm. In the absence of this proline, the
N terminus is still able to interact with DNA, although not quite as
effectively. In all in vitro reactions tested, NHP6A P18A is
very active, provided additional protein is added to compensate for the
modest effect on binding affinity. This role for proline 18 of NHP6A is
analogous to the function of proline 66 of LEF-1, which directs its
C-terminal arm into the major groove where extensive DNA contacts are
made (24). A proline to alanine substitution at the same relative
position in HMG1 box A as our NHP6A P18A mutant has also been analyzed, but it was not shown to have any effect on DNA binding (64).
The proline at position 21 of NHP6A is conserved among all
non-sequence-specific HMG1/2 proteins but corresponds to a valine or
isoleucine in sequence-specific HMG proteins. The importance of this
residue for NHP6A is shown by a 4- to over 10-fold reduction in binding
affinity of P21A to linear and microcircular DNA, respectively. NHP6A
P21A is partially defective in its ability to complement nhp6A/B mutants for growth and CUP1 expression, but
increased levels of protein largely compensate for reduced activity in
reactions in vitro. CD analysis indicates that the P21A
mutation causes a 10% loss of -helicity. Based upon the structures
of HMG-D, HMG1 box A and B, and evidence from cHMG1a (21, 22, 25, 26,
34), the conserved proline at position 21 is probably involved in
stabilizing a secondary hydrophobic pocket between helix III and the
extended peptide chain between the N terminus and the start of helix 1 (Fig. 8). Thus, the reduction in DNA binding affinity of this mutant is
attributed to a structural disruption of the N terminus of the HMG
domain and consequently the N-terminal arm.
The Hydrophobic Core of NHP6A--
Mutations at Tyr-28 and Phe-31
lead to an unfolded protein, as determined by CD analysis in
vitro and an unstable protein in vivo. The aromatic
side chains of these conserved amino acids are predicted to be directed
into the primary hydrophobic core that stabilizes the three-helix fold
(Fig. 8), as observed for other HMG box proteins (5). Interestingly,
the presence of DNA appears to stabilize the structure of F31V since it
is able to form complexes with microcircular and linear DNA with modest affinity. However, F31D is completely defective in all activities measured.
Methionine 29 Is Required for Maximal NHP6A-induced DNA
Bending--
The structures of DNA complexes formed with the
sequence-specific HMG proteins LEF-1 and SRY show that a hydrophobic
amino acid located in the N terminus of helix 1 protrudes into the DNA from the minor groove, leading to a pronounced base pair unstacking. The critical role of the intercalating isoleucine in SRY-DNA
interaction is demonstrated by the sex reversing mutation I68V, which
causes a severe defect in DNA binding and bending (23, 74, 75). Methionine 29 is located at the analogous position in NHP6A by sequence
alignment (Figs. 1A and 8). However, NHP6A M29A and even M29D binding to linear DNA is nearly indistinguishable from wild-type, and the Met-29 mutants are proficient in Hin inversion, and inducing DNA supercoiling (data not shown) in vitro. On the other
hand, NHP6A M29A only restored about 50% of the growth rate defect
that results from deleting NHP6A/B. Moreover, activated transcription of CUP1 in the presence of M29A in vivo is significantly
reduced, as well as activated transcription of
G5E4T in vitro in the presence of
M29D (and M29A to a small extent). Thus, Met-29 appears to be important
for some activities, including co-activation of transcription, but not
other HMG1-promoted functions. The different behavior of Met-29 mutants
in these reactions may be related to their ability to form microcircles
of varying lengths. Although M29A and M29D were unaltered in their
ability to form 98-bp DNA microcircles, they were completely defective
in 75-bp microcircle formation. Thus, Met-29 is not required for
productive DNA binding but is essential to induce maximum DNA
bending.
 |
ACKNOWLEDGEMENTS |
We thank Tanya Paull for yeast transcription
extracts and advice in the early part of this work, Michael Carey for
pG5E4T, GAL4- VP4 and helpful discussions,
James Bowie for assistance with circular dichroism, and Frederick
Allain for useful discussions and comments on the manuscript.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grant GM38509.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported in part by National Institutes of Health NIGMS Training
Grant GM08042, the Medical Scientist Training Program, and the
Aesculapians Fund of the UCLA School of Medicine.
¶
Supported in part by United States Public Health Service
National Research Service Award Grant GM07185.
**
Recipient of an American Cancer Society Faculty Research Award. To
whom correspondence should be addressed: Dept. of Biological Chemistry,
UCLA School of Medicine, Los Angeles, CA 90095-1737. Tel.:
310-825-7800; Fax: 310-206-5272; E-mail:
rjohnson{at}biochem.medsch.ucla.edu.
1
The abbreviations used are: HMG, high mobility
group; bp, base pair(s); PCR, polymerase chain reaction; DTT,
dithiothreitol; NLS, nuclear localization signal.
2
DICROPROT software may be obtained via FTP
(ftp.ibcp.fr).
 |
REFERENCES |
-
Bustin, M.,
and Reeves, R.
(1996)
Prog. Nucleic Acids Res. Mol. Biol.
54,
35-100[Medline]
[Order article via Infotrieve]
-
Johns, E. W.
(1982)
in
The HMG Chromosomal Proteins (Johns, E. W., ed), pp. 1-68, Academic Press, London
-
Kuehl, L.,
Salmond, B.,
and Tran, L.
(1984)
J. Cell Biol.
99,
648-654[Abstract/Free Full Text]
-
Landsman, D.,
and Bustin, M.
(1993)
BioEssays
15,
539-546[CrossRef][Medline]
[Order article via Infotrieve]
-
Grosschedl, R.,
Giese, K.,
and Pagel, J.
(1994)
Trends Genet.
10,
94-100[CrossRef][Medline]
[Order article via Infotrieve]
-
Sinclair, A. H.,
Berta, P.,
Palmer, M. S.,
Hawkins, J. R.,
Griffiths, B. L.,
Smith, M. J.,
Foster, J. W.,
Frischauf, A. M.,
Lovell-Badge, R.,
Goodfellow, P. N.
(1990)
Nature
346,
240-244[CrossRef][Medline]
[Order article via Infotrieve]
-
Gubbay, J.,
Collignon, J.,
Koopman, P.,
Capel, B.,
Economou, A.,
Munsterberg, A.,
Vivian, N.,
Goodfellow, P.,
and Lovell-Badge, R.
(1990)
Nature
346,
245-250[CrossRef][Medline]
[Order article via Infotrieve]
-
Travis, A.,
Amsterdam, A.,
Belanger, C.,
and Grosschedl, R.
(1991)
Genes Dev.
5,
880-894[Abstract/Free Full Text]
-
van de Wetering, M.,
Oosterwegel, M.,
Dooijes, D.,
and Clevers, H.
(1991)
EMBO J.
10,
123-132[Medline]
[Order article via Infotrieve]
-
Wen, L.,
Huang, J. K.,
Johnson, B. H.,
Reeck, G. R.
(1989)
Nucleic Acids Res.
17,
1197-1214[Abstract/Free Full Text]
-
Jantzen, H. M.,
Admon, A.,
Bell, S. P.,
Tjian, R.
(1990)
Nature
344,
830-836[CrossRef][Medline]
[Order article via Infotrieve]
-
Parisi, M. A.,
and Clayton, D. A.
(1991)
Science
252,
965-969[Abstract/Free Full Text]
-
Diffley, J. F.,
and Stillman, B.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
7864-7868[Abstract/Free Full Text]
-
Kolodrubetz, D.,
and Burgum, A.
(1990)
J. Biol. Chem.
265,
3234-3239[Abstract/Free Full Text]
-
Lu, J.,
Kobayashi, R.,
and Brill, S. J.
(1996)
J. Biol. Chem.
271,
33678-33685[Abstract/Free Full Text]
-
Grasser, K. D.
(1995)
Plant J.
7,
185-192[CrossRef][Medline]
[Order article via Infotrieve]
-
Wisniewski, J. R.,
and Schulze, E.
(1994)
J. Biol. Chem.
269,
10713-10719[Abstract/Free Full Text]
-
Wagner, C. R.,
Hamana, K.,
and Elgin, S. C.
(1992)
Mol. Cell. Biol.
12,
1915-1923[Abstract/Free Full Text]
-
Hayashi, T.,
Hayashi, H.,
and Iwai, K.
(1989)
J. Biochem. (Tokyo)
105,
577-581[Abstract/Free Full Text]
-
Schulman, I. G.,
Wang, T.,
Wu, M.,
Bowen, J.,
Cook, R. G.,
Gorovsky, M. A.,
Allis, C. D.
(1991)
Mol. Cell. Biol.
11,
166-174[Abstract/Free Full Text]
-
Hardman, C. H.,
Broadhurst, R. W.,
Raine, A. R.,
Grasser, K. D.,
Thomas, J. O.,
Laue, E. D.
(1995)
Biochemistry
34,
16596-16607[CrossRef][Medline]
[Order article via Infotrieve]
-
Jones, D. N.,
Searles, M. A.,
Shaw, G. L.,
Churchill, M. E.,
Ner, S. S.,
Keeler, J.,
Travers, A. A.,
Neuhaus, D.
(1994)
Structure
2,
609-627[Medline]
[Order article via Infotrieve]
-
Werner, M. H.,
Huth, J. R.,
Gronenborn, A. M.,
Clore, G. M.
(1995)
Cell
81,
705-714[CrossRef][Medline]
[Order article via Infotrieve]
-
Love, J. J.,
Li, X.,
Case, D. A.,
Giese, K.,
Grosschedl, R.,
Wright, P. E.
(1995)
Nature
376,
791-795[CrossRef][Medline]
[Order article via Infotrieve]
-
Weir, H. M.,
Kraulis, P. J.,
Hill, C. S.,
Raine, A. R.,
Laue, E. D.,
Thomas, J. O.
(1993)
EMBO J.
12,
1311-1319[Medline]
[Order article via Infotrieve]
-
Read, C. M.,
Cary, P. D.,
Crane-Robinson, C.,
Driscoll, P. C.,
Norman, D. G.
(1993)
Nucleic Acids Res.
21,
3427-3436[Abstract/Free Full Text]
-
van Houte, L. P.,
Chuprina, V. P.,
van der Wetering, M.,
Boelens, R.,
Kaptein, R.,
Clevers, H.
(1995)
J. Biol. Chem.
270,
30516-30524[Abstract/Free Full Text]
-
Bianchi, M. E.,
Beltrame, M.,
and Paonessa, G.
(1989)
Science
243,
1056-1059[Abstract/Free Full Text]
-
Pil, P. M.,
and Lippard, S. J.
(1992)
Science
256,
234-237[Abstract/Free Full Text]
-
Payet, D.,
and Travers, A.
(1997)
J. Mol. Biol.
266,
66-75[CrossRef][Medline]
[Order article via Infotrieve]
-
Locker, D.,
Decoville, M.,
Maurizot, J. C.,
Bianchi, M. E.,
Leng, M.
(1995)
J. Mol. Biol.
246,
243-247[CrossRef][Medline]
[Order article via Infotrieve]
-
Farid, R. S.,
Bianchi, M. E.,
Falciola, L.,
Engelsberg, B. N.,
Billings, P. C.
(1996)
Toxicol. Appl. Pharmacol.
141,
532-539[CrossRef][Medline]
[Order article via Infotrieve]
-
Paull, T. T.,
and Johnson, R. C.
(1995)
J. Biol. Chem.
270,
8744-8754[Abstract/Free Full Text]
-
Wisniewski, J. R.,
Hessler, K.,
Claus, P.,
and Zechel, K.
(1997)
Eur. J. Biochem.
243,
151-159[Medline]
[Order article via Infotrieve]
-
Carlsson, P.,
Waterman, M. L.,
and Jones, K. A.
(1993)
Genes Dev.
7,
2418-2430[Abstract/Free Full Text]
-
Lnenicek-Allen, M.,
Read, C. M.,
and Crane-Robinson, C.
(1996)
Nucleic Acids Res.
24,
1047-1051[Abstract/Free Full Text]
-
Teo, S. H.,
Grasser, K. D.,
and Thomas, J. O.
(1995)
Eur. J. Biochem.
230,
943-950[Medline]
[Order article via Infotrieve]
-
Paull, T. T.,
Haykinson, M. J.,
and Johnson, R. C.
(1993)
Genes Dev.
7,
1521-1534[Abstract/Free Full Text]
-
Segall, A. M.,
Goodman, S. D.,
and Nash, H. A.
(1994)
EMBO J.
13,
4536-4548[Medline]
[Order article via Infotrieve]
-
Lavoie, B. D.,
and Chaconas, G.
(1994)
J. Biol. Chem.
269,
15571-15576[Abstract/Free Full Text]
-
Paull, T. T.,
Carey, M.,
and Johnson, R. C.
(1996)
Genes Dev.
10,
2769-2781[Abstract/Free Full Text]
-
Bonne-Andrea, C.,
Harper, F.,
Puvion, E.,
Delpech, M.,
and De Recondo, A. M.
(1986)
Biol. Cell
58,
185-914[Medline]
[Order article via Infotrieve]
-
Kuhn, A.,
Voit, R.,
Stefanovsky, V.,
Evers, R.,
Bianchi, M.,
and Grummt, I.
(1994)
EMBO J.
13,
416-424[Medline]
[Order article via Infotrieve]
-
Nightingale, K.,
Dimitrov, S.,
Reeves, R.,
and Wolffe, A. P.
(1996)
EMBO J.
15,
548-561[Medline]
[Order article via Infotrieve]
-
Ura, K.,
Nightingale, K.,
and Wolffe, A. P.
(1996)
EMBO J.
15,
4959-4969[Medline]
[Order article via Infotrieve]
-
Shykind, B. M.,
Kim, J.,
and Sharp, P. A.
(1995)
Genes Dev.
9,
1354-1365[Abstract/Free Full Text]
-
Ge, H.,
and Roeder, R. G.
(1994)
J. Biol. Chem.
269,
17136-17140[Abstract/Free Full Text]
-
Stelzer, G.,
Goppelt, A.,
Lottspeich, F.,
and Meisterernst, M.
(1994)
Mol. Cell. Biol.
14,
4712-4721[Abstract/Free Full Text]
-
Kirov, N. C.,
Lieberman, P. M.,
and Rushlow, C.
(1996)
EMBO J.
15,
7079-7087[Medline]
[Order article via Infotrieve]
-
Costigan, C.,
Kolodrubetz, D.,
and Snyder, M.
(1994)
Mol. Cell. Biol.
14,
2391-2403[Abstract/Free Full Text]
-
Kunkel, T. A.,
Roberts, J. D.,
and Zakour, R. A.
(1987)
Methods Enzymol.
154,
367-382[Medline]
[Order article via Infotrieve]
-
McClary, J. A.,
Witney, F.,
and Geisselsoder, J.
(1989)
BioTechniques
7,
282-289 [Medline]
[Order article via Infotrieve]
-
Sikorski, R. S.,
and Hieter, P.
(1989)
Genetics
122,
19-27[Abstract/Free Full Text]
-
Bianchi, M. E.
(1991)
Gene (Amst.)
104,
271-275[CrossRef][Medline]
[Order article via Infotrieve]
-
Wagner, J. P.,
Quill, D. M.,
and Pettijohn, D. E.
(1995)
J. Biol. Chem.
270,
7394-7398[Abstract/Free Full Text]
-
Haykinson, M. J.,
and Johnson, R. C.
(1993)
EMBO J.
12,
2503-2512[Medline]
[Order article via Infotrieve]
-
Rose, M. D.,
Winston, F.,
and P., H.
(1990)
Methods in Yeast Genetics: A Laboratory Course Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
-
Durrin, L. K.,
Mann, R. K.,
and Grunstein, M.
(1992)
Mol. Cell. Biol.
12,
1621-1629[Abstract/Free Full Text]
-
Ohashi, Y.,
Brickman, J. M.,
Furman, E.,
Middleton, B.,
and Carey, M.
(1994)
Mol. Cell. Biol.
14,
2731-2739[Abstract/Free Full Text]
-
Deleage, G.,
and Geourjon, C.
(1993)
Comput. Appl. Biosci.
9,
197-199[Abstract/Free Full Text]
-
Bianchi, M. E.,
Falciola, L.,
Ferrari, S.,
and Lilley, D. M.
(1992)
EMBO J.
11,
1055-1063[Medline]
[Order article via Infotrieve]
-
Sreerama, N.,
and Woody, R. W.
(1993)
Anal. Biochem.
209,
32-44[CrossRef][Medline]
[Order article via Infotrieve]
-
Read, C. M.,
Cary, P. D.,
Preston, N. S.,
Lnenicek-Allen, M.,
Crane-Robinson, C.
(1994)
EMBO J.
13,
5639-5646[Medline]
[Order article via Infotrieve]
-
Teo, S. H.,
Grasser, K. D.,
Hardman, C. H.,
Broadhurst, R. W.,
Laue, E. D.,
Thomas, J. O.
(1995)
EMBO J.
14,
3844-3853[Medline]
[Order article via Infotrieve]
-
Pil, P. M.,
Chow, C. S.,
and Lippard, S. J.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
9465-9469[Abstract/Free Full Text]
-
Churchill, M. E.,
Jones, D. N.,
Glaser, T.,
Hefner, H.,
Searles, M. A.,
Travers, A. A.
(1995)
EMBO J.
14,
1264-1275[Medline]
[Order article via Infotrieve]
-
Shore, D.,
Langowski, J.,
and Baldwin, R. L.
(1981)
Proc. Natl. Acad. Sci. U. S. A.
78,
4833-4837[Abstract/Free Full Text]
-
Heyduk, E.,
Heyduk, T.,
Claus, P.,
and Wisniewski, J. R.
(1997)
J. Biol. Chem.
272,
19763-19770[Abstract/Free Full Text]
-
LaCasse, E. C.,
and Lefebvre, Y. A.
(1995)
Nucleic Acids Res.
23,
1647-1656[Free Full Text]
-
Maeda, Y.,
Hisatake, K.,
Kondo, T.,
Hanada, K.,
Song, C. Z.,
Nishimura, T.,
Muramatsu, M.
(1992)
EMBO J.
11,
3695-3704[Medline]
[Order article via Infotrieve]
-
Sudbeck, P.,
and Scherer, G.
(1997)
J. Biol. Chem.
272,
27848-27852[Abstract/Free Full Text]
-
Prieve, M. G.,
Guttridge, K. L.,
Munguia, J. E.,
Waterman, M. L.
(1996)
J. Biol. Chem.
271,
7654-7658[Abstract/Free Full Text]
-
Poulat, F.,
Girard, F.,
Chevron, M. P.,
Goze, C.,
Rebillard, X.,
Calas, B.,
Lamb, N.,
Berta, P.
(1995)
J. Cell Biol.
128,
737-748[Abstract/Free Full Text]
-
King, C. Y.,
and Weiss, M. A.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
11990-11994[Abstract/Free Full Text]
-
Haqq, C. M.,
King, C. Y.,
Ukiyama, E.,
Falsafi, S.,
Haqq, T. N.,
Donahoe, P. K.,
Weiss, M. A.
(1994)
Science
266,
1494-1500[Abstract/Free Full Text]
-
Baxevanis, A. D.,
Bryant, S. H.,
and Landsman, D.
(1995)
Nucleic Acids Res.
23,
1019-1029[Abstract/Free Full Text]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Briquet, C. Boschet, M. Gissot, E. Tissandie, E. Sevilla, J.-F. Franetich, I. Thiery, Z. Hamid, C. Bourgouin, and C. Vaquero
High-Mobility-Group Box Nuclear Factors of Plasmodium falciparum.
Eukaryot. Cell,
April 1, 2006;
5(4):
672 - 682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Dai, B. Wong, Y.-M. Yen, M. A. Oettinger, J. Kwon, and R. C. Johnson
Determinants of HMGB Proteins Required To Promote RAG1/2-Recombination Signal Sequence Complex Assembly and Catalysis during V(D)J Recombination
Mol. Cell. Biol.,
June 1, 2005;
25(11):
4413 - 4425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kamau, K. T. Bauerle, and A. Grove
The Saccharomyces cerevisiae High Mobility Group Box Protein HMO1 Contains Two Functional DNA Binding Domains
J. Biol. Chem.,
December 31, 2004;
279(53):
55234 - 55240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Shivaswamy, G. A. Kassavetis, and P. Bhargava
High-Level Activation of Transcription of the Yeast U6 snRNA Gene in Chromatin by the Basal RNA Polymerase III Transcription Factor TFIIIC
Mol. Cell. Biol.,
May 1, 2004;
24(9):
3596 - 3606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ruone, A. R. Rhoades, and T. Formosa
Multiple Nhp6 Molecules Are Required to Recruit Spt16-Pob3 to Form yFACT Complexes and to Reorganize Nucleosomes
J. Biol. Chem.,
November 14, 2003;
278(46):
45288 - 45295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Klass, F. V. Murphy IV, S. Fouts, M. Serenil, A. Changela, J. Siple, and M. E. A. Churchill
The role of intercalating residues in chromosomal high-mobility-group protein DNA binding, bending and specificity
Nucleic Acids Res.,
June 1, 2003;
31(11):
2852 - 2864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Formosa, S. Ruone, M. D. Adams, A. E. Olsen, P. Eriksson, Y. Yu, A. R. Rhoades, P. D. Kaufman, and D. J. Stillman
Defects in SPT16 or POB3 (yFACT) in Saccharomyces cerevisiae Cause Dependence on the Hir/Hpc Pathway: Polymerase Passage May Degrade Chromatin Structure
Genetics,
December 1, 2002;
162(4):
1557 - 1571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Mitsouras, B. Wong, C. Arayata, R. C. Johnson, and M. Carey
The DNA Architectural Protein HMGB1 Displays Two Distinct Modes of Action That Promote Enhanceosome Assembly
Mol. Cell. Biol.,
June 15, 2002;
22(12):
4390 - 4401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kanaya, N. Nakajima, and K. Okada
Non-sequence-specific DNA Binding by the FILAMENTOUS FLOWER Protein from Arabidopsis thaliana Is Reduced by EDTA
J. Biol. Chem.,
March 29, 2002;
277(14):
11957 - 11964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Martin, V. L. Gerlach, and D. A. Brow
A Novel Upstream RNA Polymerase III Promoter Element Becomes Essential When the Chromatin Structure of the Yeast U6 RNA Gene Is Altered
Mol. Cell. Biol.,
October 1, 2001;
21(19):
6429 - 6439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. K. Brewster, G. C. Johnston, and R. A. Singer
A Bipartite Yeast SSRP1 Analog Comprised of Pob3 and Nhp6 Proteins Modulates Transcription
Mol. Cell. Biol.,
May 15, 2001;
21(10):
3491 - 3502.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Lopez, M. Livingstone-Zatchej, S. Jourdain, F. Thoma, A. Sentenac, and M.-C. Marsolier
High-Mobility-Group Proteins NHP6A and NHP6B Participate in Activation of the RNA Polymerase III SNR6 Gene
Mol. Cell. Biol.,
May 1, 2001;
21(9):
3096 - 3104.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. B. Ellwood, Y.-M. Yen, R. C. Johnson, and M. Carey
Mechanism for Specificity by HMG-1 in Enhanceosome Assembly
Mol. Cell. Biol.,
June 15, 2000;
20(12):
4359 - 4370.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. van Beest, D. Dooijes, M. van de Wetering, S. Kjaerulff, A. Bonvin, O. Nielsen, and H. Clevers
Sequence-specific High Mobility Group Box Factors Recognize 10-12-Base Pair Minor Groove Motifs
J. Biol. Chem.,
August 25, 2000;
275(35):
27266 - 27273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Stros and E. Muselikova
A Role of Basic Residues and the Putative Intercalating Phenylalanine of the HMG-1 Box B in DNA Supercoiling and Binding to Four-way DNA Junctions
J. Biol. Chem.,
November 10, 2000;
275(46):
35699 - 35707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Stemmer, A. Schwander, G. Bauw, P. Fojan, and K. D. Grasser
Protein Kinase CK2 Differentially Phosphorylates Maize Chromosomal High Mobility Group B (HMGB) Proteins Modulating Their Stability and DNA Interactions
J. Biol. Chem.,
January 4, 2002;
277(2):
1092 - 1098.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|